相似文献
1
Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis.
Nat Immunol. 2009 Nov;10(11):1178-84. doi: 10.1038/ni.1791. Epub 2009 Sep 27.
2
Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
Sci Rep. 2016 Sep 1;6:32415. doi: 10.1038/srep32415.
3
The gut feeling of Treg cells: IL-10 is the silver lining during colitis.
Nat Immunol. 2009 Nov;10(11):1141-3. doi: 10.1038/ni1109-1141.
4
IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
Nat Immunol. 2008 Dec;9(12):1347-55. doi: 10.1038/ni.1677. Epub 2008 Nov 9.
5
Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3 Tregs.
Front Immunol. 2021 Feb 26;12:637630. doi: 10.3389/fimmu.2021.637630. eCollection 2021.
6
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12204-9. doi: 10.1073/pnas.0909122107. Epub 2010 Jun 21.
7
Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology.
J Exp Med. 2011 May 9;208(5):1027-40. doi: 10.1084/jem.20102149. Epub 2011 Apr 25.
8
RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
J Immunol. 2021 Oct 15;207(8):2027-2038. doi: 10.4049/jimmunol.2100175. Epub 2021 Sep 13.
9
Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
Nat Immunol. 2007 Sep;8(9):931-41. doi: 10.1038/ni1504. Epub 2007 Aug 12.
10
Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
Gastroenterology. 2011 Jun;140(7):2031-43. doi: 10.1053/j.gastro.2011.03.009. Epub 2011 Mar 17.
引用本文的文献
1
CREB regulates Foxp3ST-2 T with enhanced IL-10 production.
Front Immunol. 2025 Jul 24;16:1601008. doi: 10.3389/fimmu.2025.1601008. eCollection 2025.
2
Unveiling the nexus between direct-acting antivirals in hepatitis C virus elimination and immune response.
Clin Exp Med. 2025 Jul 30;25(1):269. doi: 10.1007/s10238-025-01811-y.
3
Bronchial anastomotic complications as a microvascular disruption in a mouse model of airway transplantation.
Front Immunol. 2025 May 14;16:1567657. doi: 10.3389/fimmu.2025.1567657. eCollection 2025.
4
ERMAP attenuates DSS-induced colitis in mice by regulating macrophage and T cell functions.
BMC Gastroenterol. 2025 May 12;25(1):362. doi: 10.1186/s12876-025-03840-z.
5
Gut Expansion of a Human Lupus Pathobiont is Associated With Autoantibody Production and T Cell Dysregulation.
ACR Open Rheumatol. 2025 May;7(5):e70033. doi: 10.1002/acr2.70033.
6
Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency.
J Exp Med. 2025 Aug 4;222(8). doi: 10.1084/jem.20241993. Epub 2025 May 2.
7
The Intestinal Macrophage-Intestinal Stem Cell Axis in Inflammatory Bowel Diseases: From Pathogenesis to Therapy.
Int J Mol Sci. 2025 Mar 21;26(7):2855. doi: 10.3390/ijms26072855.
8
Long noncoding RNA BCYRN1 promotes cardioprotection by enhancing human and murine regulatory T cell dynamics.
J Clin Invest. 2025 Mar 25;135(9). doi: 10.1172/JCI179262. eCollection 2025 May 1.
9
Post-stroke depression: exploring gut microbiota-mediated barrier dysfunction through immune regulation.
Front Immunol. 2025 Mar 3;16:1547365. doi: 10.3389/fimmu.2025.1547365. eCollection 2025.
10
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.
Signal Transduct Target Ther. 2025 Mar 7;10(1):93. doi: 10.1038/s41392-025-02124-y.
本文引用的文献
1
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.
Nat Immunol. 2009 Sep;10(9):1000-7. doi: 10.1038/ni.1774. Epub 2009 Jul 26.
2
Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches.
Science. 2009 Mar 13;323(5920):1488-92. doi: 10.1126/science.1169152.
3
Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1903-8. doi: 10.1073/pnas.0811556106. Epub 2009 Jan 27.
4
A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells.
Nat Immunol. 2008 Jun;9(6):632-40. doi: 10.1038/ni.1607. Epub 2008 Apr 27.
5
Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.
Immunity. 2008 Apr;28(4):546-58. doi: 10.1016/j.immuni.2008.02.017.
6
Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice.
J Clin Invest. 2008 Feb;118(2):735-41. doi: 10.1172/JCI32562.
7
Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses.
Nat Immunol. 2007 Oct;8(10):1086-94. doi: 10.1038/ni1511. Epub 2007 Sep 16.
8
Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B.
Nat Immunol. 2007 Oct;8(10):1095-104. doi: 10.1038/ni1503. Epub 2007 Sep 2.
9
Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.
J Immunol. 2007 Jun 1;178(11):6725-9. doi: 10.4049/jimmunol.178.11.6725.
10
T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.
Immunity. 2007 May;26(5):579-91. doi: 10.1016/j.immuni.2007.03.014. Epub 2007 May 3.
Zotero 插件